Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2023
Institutional positions in Nuvalent, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 111
- +22 vs. Q1 2023
- Shares held
- 55.3M
- +1.09M (+2.0%) vs. Q1 2023
- Total value
- $2.33B
- +$920.0M (+65.2%) vs. Q1 2023
- New holders
- 30
- 37 more added
- Sold out
- 8
- 33 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 292 | $9.29B |
| Q1 2026 | 265 | $8.30B |
| Q4 2025 | 237 | $8.04B |
| Q3 2025 | 196 | $6.26B |
| Q2 2025 | 209 | $5.49B |
| Q1 2025 | 205 | $5.11B |
| Q4 2024 | 217 | $5.53B |
| Q3 2024 | 193 | $7.17B |
| Q2 2024 | 172 | $4.98B |
| Q1 2024 | 180 | $4.78B |
| Q4 2023 | 155 | $4.68B |
| Q3 2023 | 116 | $2.57B |
| Q2 2023 | 111 | $2.33B |
| Q1 2023 | 89 | $1.41B |
| Q4 2022 | 96 | $1.58B |
| Q3 2022 | 60 | $879.5M |
| Q2 2022 | 55 | $622.5M |
| Q1 2022 | 55 | $629.0M |
| Q4 2021 | 49 | $813.1M |
| Q3 2021 | 47 | $941.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Nuvalent, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 1,210,192 | $51.0M | 2.37% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 1,440,730 | $60.8M | 0.77% | +38,205+2.7% | Added |
| Avoro Capital Advisors LLC | 1,600,000 | $67.5M | 0.92% | −288,888−15.3% | Reduced |
| Wellington Management Group LLP | 1,736,487 | $73.2M | 0.01% | −150,189−8.0% | Reduced |
| Vanguard Group Inc | 2,118,460 | $89.3M | 0.00% | +48,214+2.3% | Added |
| Perceptive Advisors LLC | 2,194,821 | $92.6M | 2.69% | −105,227−4.6% | Reduced |
| BlackRock Inc. | 2,396,864 | $101.1M | 0.00% | +200,966+9.2% | Added |
| Fairmount Funds Management LLC | 2,884,492 | $121.6M | 17.15% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $150.9M | 15.54% | 00.0% | Unchanged |
| FMR LLC | 7,618,124 | $321.3M | 0.03% | −72,300−0.9% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 19,991,024 | $843.0M | 18.00% | 00.0% | Unchanged |
| Millennium Management LLC | 0 | $0 | 0.00% | −57,633−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −17,897−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,300−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −9,441−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −8,982−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,095−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −83,697−100.0% | Sold out |